InsiderTrades.com logo

BHVN Insider Trading

Insider Ownership Percentage: 16.00%
Insider Buying (Last 12 Months): $35,183,461.50
Insider Selling (Last 12 Months): $0.00

Biohaven Insider Trading History Chart

This chart shows the insider buying and selling history at Biohaven by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Biohaven Share Price & Price History

Current Price: $9.60
Price Change: ▲ Price Increase of +0.48 (5.26%)
As of 12/4/2025 04:59 PM ET

This chart shows the closing price history over time for BHVN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Biohaven Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2025George C. ClarkCAOBuy17,000$8.52$144,840.0020,000View SEC Filing Icon  
11/13/2025Gregory H. BaileyDirectorBuy400,000$7.50$3,000,000.002,020,071View SEC Filing Icon  
11/13/2025John W. ChildsDirectorBuy3,333,333$7.50$24,999,997.505,653,904View SEC Filing Icon  
11/13/2025Vlad CoricCEOBuy666,666$7.50$4,999,995.001,195,275View SEC Filing Icon  
3/4/2025John W. ChildsDirectorBuy32,700$30.47$996,369.002,320,571View SEC Filing Icon  
12/30/2024John W. ChildsDirectorBuy29,000$35.94$1,042,260.002,368,741View SEC Filing Icon  
10/2/2024John W. ChildsDirectorBuy21,052$47.50$999,970.0021,052View SEC Filing Icon  
9/24/2024Gregory H. BaileyDirectorBuy5,000$44.19$220,950.001,620,071View SEC Filing Icon  
7/18/2024John W. ChildsDirectorBuy28,400$35.67$1,013,028.002,339,741View SEC Filing Icon  
5/30/2024John W. ChildsDirectorBuy28,000$35.58$996,240.002,311,341View SEC Filing Icon  
5/13/2024John W. ChildsDirectorBuy28,500$35.17$1,002,345.002,283,341View SEC Filing Icon  
4/24/2024Gregory H. BaileyDirectorBuy25,503$39.18$999,207.541,600,071View SEC Filing Icon  
4/22/2024Gregory H. BaileyDirectorBuy48,780$41.00$1,999,980.001,574,568View SEC Filing Icon  
4/22/2024Vlad CoricCEOBuy121,951$41.00$4,999,991.001,788,417View SEC Filing Icon  
12/29/2023Irina AntonijevicDirectorSell11,000$41.79$459,690.002,535View SEC Filing Icon  
10/5/2023Matthew ButenCFOBuy22,727$22.00$499,994.00189,380View SEC Filing Icon  
10/5/2023Vlad CoricCEOBuy113,637$22.00$2,500,014.001,657,031View SEC Filing Icon  
10/4/2023Gregory H. BaileyDirectorBuy17,817$22.57$402,129.691,525,788View SEC Filing Icon  
8/30/2023John W. ChildsDirectorBuy50,000$18.44$922,000.001,975,118View SEC Filing Icon  
8/4/2023John W. ChildsDirectorBuy100,000$19.78$1,978,000.001,925,118View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Biohaven (NYSE:BHVN)

88.78% of Biohaven stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BHVN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Biohaven Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025XTX Topco Ltd63,639$0.96M0.0%N/A0.060%Search for SEC Filing on Google Icon
11/17/2025Alyeska Investment Group L.P.200,000$3M0.0%N/A0.189%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC146,180$2.19M0.0%+19.4%0.138%Search for SEC Filing on Google Icon
11/17/2025Quantessence Capital LLC62,979$0.95M0.3%N/A0.059%Search for SEC Filing on Google Icon
11/17/2025Quarry LP10,000$0.15M0.0%N/A0.009%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd1,265,597$19M0.0%+834.4%1.196%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.50,391$0.75M0.0%-45.5%0.048%Search for SEC Filing on Google Icon
11/17/2025Lighthouse Investment Partners LLC35,000$0.53M0.0%N/A0.033%Search for SEC Filing on Google Icon
11/17/2025Holocene Advisors LP765,874$11.50M0.0%-48.8%0.723%Search for SEC Filing on Google Icon
11/17/2025Focus Partners Wealth5,829$87K0.0%N/A0.006%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE788,331$11.83M0.0%+87.5%0.745%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC136,290$2.05M0.0%+18.0%0.129%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.157,972$2.37M0.0%-13.1%0.149%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC40,886$0.61M0.0%N/A0.039%Search for SEC Filing on Google Icon
11/14/2025Creative Planning16,112$0.24M0.0%+46.8%0.015%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.92,045$1.38M0.0%+182.2%0.087%Search for SEC Filing on Google Icon
11/14/2025California State Teachers Retirement System80,150$1.20M0.0%+7.6%0.076%Search for SEC Filing on Google Icon
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC571,911$8.58M0.0%-18.7%0.540%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP799,600$12M0.0%+986.0%0.755%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC241,423$3.62M0.0%N/A0.228%Search for SEC Filing on Google Icon
11/14/2025Prosight Management LP600,000$9.01M2.1%+11.3%0.567%Search for SEC Filing on Google Icon
11/14/2025Integral Health Asset Management LLC650,000$9.76M0.7%+116.7%0.614%Search for SEC Filing on Google Icon
11/13/2025Sei Investments Co.39,325$0.59M0.0%-16.5%0.037%Search for SEC Filing on Google Icon
11/13/2025Capital Fund Management S.A.152,886$2.30M0.0%-41.5%0.144%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets843,564$12.66M0.0%+34.2%0.797%Search for SEC Filing on Google Icon
11/13/2025Franklin Resources Inc.20,709$0.31M0.0%-66.0%0.020%Search for SEC Filing on Google Icon
11/13/2025Capital Research Global Investors1,011,530$15.18M0.0%+108.9%0.956%Search for SEC Filing on Google Icon
11/13/2025Swiss National Bank168,300$2.53M0.0%+1.1%0.159%Search for SEC Filing on Google Icon
11/13/2025WINTON GROUP Ltd27,099$0.41M0.0%N/A0.026%Search for SEC Filing on Google Icon
11/12/2025Victory Capital Management Inc.16,270$0.24M0.0%-73.3%0.015%Search for SEC Filing on Google Icon
11/12/2025Rafferty Asset Management LLC163,569$2.46M0.0%+35.0%0.155%Search for SEC Filing on Google Icon
11/12/2025Quantbot Technologies LP6,455$97K0.0%-27.0%0.006%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC58,575$0.88M0.0%-9.0%0.055%Search for SEC Filing on Google Icon
11/12/2025Fox Run Management L.L.C.51,672$0.78M0.1%+197.0%0.049%Search for SEC Filing on Google Icon
11/10/2025RWA Wealth Partners LLC24,022$0.36M0.0%N/A0.023%Search for SEC Filing on Google Icon
11/10/2025TD Asset Management Inc136,028$2.04M0.0%-53.3%0.129%Search for SEC Filing on Google Icon
11/10/2025Ameritas Investment Partners Inc.7,558$0.11M0.0%-15.9%0.007%Search for SEC Filing on Google Icon
11/10/2025Mitsubishi UFJ Asset Management UK Ltd.15,000$0.23M0.1%N/A0.014%Search for SEC Filing on Google Icon
11/7/2025Fiera Capital Corp561,354$8.43M0.0%-2.4%0.531%Search for SEC Filing on Google Icon
11/7/2025NewEdge Wealth LLC246,553$3.70M0.1%+1.3%0.233%Search for SEC Filing on Google Icon
11/7/2025Readystate Asset Management LP377,119$5.66M0.2%+14.1%0.356%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.2,875,190$43.16M0.0%-68.9%2.718%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.1,335,455$20.05M0.0%-48.1%1.262%Search for SEC Filing on Google Icon
11/7/2025PNC Financial Services Group Inc.2,383$36K0.0%+113.7%0.002%Search for SEC Filing on Google Icon
11/7/2025Warner Group LLC14,587$0.22M0.2%N/A0.014%Search for SEC Filing on Google Icon
11/6/2025Assetmark Inc.22,830$0.34M0.0%+9.9%0.022%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers133,920$2.01M0.0%-2.5%0.127%Search for SEC Filing on Google Icon
11/6/2025Profund Advisors LLC35,398$0.53M0.0%+37.4%0.033%Search for SEC Filing on Google Icon
11/6/2025ProShare Advisors LLC15,469$0.23M0.0%-16.6%0.015%Search for SEC Filing on Google Icon
11/6/2025Oppenheimer & Co. Inc.31,444$0.47M0.0%N/A0.030%Search for SEC Filing on Google Icon
11/5/2025Optimize Financial Inc26,768$0.40M0.2%N/A0.025%Search for SEC Filing on Google Icon
11/4/2025WCM Investment Management LLC287,860$4.22M0.0%-1.4%0.272%Search for SEC Filing on Google Icon
11/3/2025Coastal Bridge Advisors LLC33,772$0.51M0.0%-8.5%0.032%Search for SEC Filing on Google Icon
10/31/2025Y Intercept Hong Kong Ltd172,216$2.59M0.1%-31.6%0.163%Search for SEC Filing on Google Icon
10/30/2025Emerald Mutual Fund Advisers Trust173,656$2.61M0.1%+0.4%0.164%Search for SEC Filing on Google Icon
10/30/2025Universal Beteiligungs und Servicegesellschaft mbH10,382$0.16M0.0%N/A0.010%Search for SEC Filing on Google Icon
10/23/2025Nisa Investment Advisors LLC23,975$0.36M0.0%+735.1%0.023%Search for SEC Filing on Google Icon
10/23/2025Canton Hathaway LLC26,400$0.40M0.1%-13.4%0.025%Search for SEC Filing on Google Icon
10/23/2025SG Americas Securities LLC26,933$0.40M0.0%+106.2%0.025%Search for SEC Filing on Google Icon
10/22/2025SeaBridge Investment Advisors LLC17,815$0.27M0.0%-5.9%0.017%Search for SEC Filing on Google Icon
10/22/2025Hennion & Walsh Asset Management Inc.33,727$0.51M0.0%+70.0%0.032%Search for SEC Filing on Google Icon
10/20/2025VIRGINIA RETIREMENT SYSTEMS ET Al22,900$0.34M0.0%+32.4%0.022%Search for SEC Filing on Google Icon
10/20/2025Weybosset Research & Management LLC22,940$0.34M0.1%+19.0%0.022%Search for SEC Filing on Google Icon
10/20/2025Simplify Asset Management Inc.109,685$1.65M0.0%+13.8%0.104%Search for SEC Filing on Google Icon
10/17/2025Constitution Capital LLC17,000$0.26M0.1%N/A0.016%Search for SEC Filing on Google Icon
10/16/2025PFS Partners LLC4,000$60K0.0%N/A0.004%Search for SEC Filing on Google Icon
10/15/2025CWM LLC11,159$0.17M0.0%+38.9%0.011%Search for SEC Filing on Google Icon
10/15/2025Inspire Investing LLC30,479$0.46M0.0%+10.1%0.029%Search for SEC Filing on Google Icon
10/15/2025ARS Investment Partners LLC1,102,549$16.55M1.1%-7.2%1.042%Search for SEC Filing on Google Icon
10/14/2025Exchange Traded Concepts LLC44,793$0.67M0.0%+14.4%0.042%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC16,464$0.25M0.0%-32.8%0.016%Search for SEC Filing on Google Icon
9/4/2025Osaic Holdings Inc.9,791$0.15M0.0%+150.5%0.009%Search for SEC Filing on Google Icon
8/28/2025China Universal Asset Management Co. Ltd.20,000$0.28M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/27/2025Orion Porfolio Solutions LLC16,659$0.24M0.0%-8.5%0.016%Search for SEC Filing on Google Icon
8/15/2025Tower Research Capital LLC TRC 8,031$0.11M0.0%+198.6%0.008%Search for SEC Filing on Google Icon
8/15/2025E Fund Management Co. Ltd.13,492$0.19M0.0%+20.6%0.013%Search for SEC Filing on Google Icon
8/15/2025Rafferty Asset Management LLC121,189$1.71M0.0%+1.3%0.115%Search for SEC Filing on Google Icon
8/15/2025Oxford Asset Management LLP37,970$0.54M0.2%N/A0.036%Search for SEC Filing on Google Icon
8/15/2025Orion Porfolio Solutions LLC16,659$0.24M0.0%-8.5%0.016%Search for SEC Filing on Google Icon
8/15/2025Man Group plc63,407$0.90M0.0%N/A0.060%Search for SEC Filing on Google Icon
8/15/2025Holocene Advisors LP1,495,641$21.10M0.1%+19.1%1.414%Search for SEC Filing on Google Icon
8/15/2025Elkhorn Partners Limited Partnership5,800$82K0.1%+26.1%0.005%Search for SEC Filing on Google Icon
8/15/2025Eventide Asset Management LLC300,000$4.23M0.1%-46.4%0.284%Search for SEC Filing on Google Icon
8/15/2025Engineers Gate Manager LP42,720$0.60M0.0%N/A0.040%Search for SEC Filing on Google Icon
8/15/2025Cubist Systematic Strategies LLC658,355$9.29M0.0%N/A0.622%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets628,622$8.87M0.0%+6,907.3%0.594%Search for SEC Filing on Google Icon
8/15/2025Bellevue Group AG2,802,853$39.55M0.9%+37.3%2.649%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE420,501$5.93M0.0%+13.3%0.397%Search for SEC Filing on Google Icon
8/15/2025Adage Capital Partners GP L.L.C.630,033$8.89M0.0%+14.3%0.596%Search for SEC Filing on Google Icon
8/15/2025Ameriprise Financial Inc.181,855$2.57M0.0%-66.0%0.172%Search for SEC Filing on Google Icon
8/14/2025PDT Partners LLC27,800$0.39M0.0%N/A0.026%Search for SEC Filing on Google Icon
8/14/2025California State Teachers Retirement System74,486$1.05M0.0%-6.2%0.070%Search for SEC Filing on Google Icon
8/14/2025Raymond James Financial Inc.32,614$0.46M0.0%+40.8%0.031%Search for SEC Filing on Google Icon
8/14/2025Redmile Group LLC729,515$10.29M1.1%-15.9%0.690%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.92,446$1.30M0.0%+28.7%0.087%Search for SEC Filing on Google Icon
8/14/2025Armistice Capital LLC2,136,000$30.14M0.5%+27.6%2.019%Search for SEC Filing on Google Icon
8/14/2025Mark Asset Management LP19,300$0.27M0.0%N/A0.018%Search for SEC Filing on Google Icon
8/14/2025The Manufacturers Life Insurance Company 236,154$3.33M0.0%+35.5%0.223%Search for SEC Filing on Google Icon
8/14/2025Sei Investments Co.47,113$0.67M0.0%-31.8%0.045%Search for SEC Filing on Google Icon
8/14/2025Stempoint Capital LP174,754$2.47M0.8%-30.3%0.165%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Biohaven logo
Biohaven Ltd., together with its subsidiaries, focuses on discovering, developing, and commercializing therapies for immunology, neuroscience, and oncology worldwide. The company's pipeline products include Troriluzole, which is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500 that blocks glutamate signaling mediated by post-synaptic NMDA receptors; Taldefgrobep Alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 2/3 clinical trials for the treatment of focal and generalized epilepsy, bipolar disorder, and major depressive disorder; BHV-2100 that is in Phase 1 clinical trials for the treatment of migraines and neuropathic pain; and BHV-8000, a product candidate in Phase 1 clinical trials for the treatment of early Alzheimer's and Parkinson's disease, sclerosis, and amyloid-related imaging abnormalities. It also offers BHV-1300, a product candidate in Phase 1 clinical trials to treat rheumatoid arthritis; BHV-1310 for the treatment of generalized myasthenia gravis and acute exacerbations or flares; BHV-1400 to treat IgA Nephropathy; and BHV-1600 for the treatment of dilated cardiomyopathy. In addition, the company develops BHV-1100, a product candidate in Phase 1a/1b clinical trials for multiple myeloma patients; BHV-1510, a preclinical product that targets carcinomas; and BHV-1500 for Hodgkin's lymphoma. It has license, development, and commercialization agreements with Yale University, AstraZeneca, University of Connecticut, Artizan Biosciences Inc., Reliant Glycosciences LLC, Katholieke Universiteit Leuven, BMS, and Highlightll Pharmaceutical Co. Ltd. The company was formerly known as Biohaven Research Ltd and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.
Read More on Biohaven

Today's Range

Now: $9.60
Low: $8.98
High: $9.68

50 Day Range

MA: $13.00
Low: $7.81
High: $18.08

52 Week Range

Now: $9.60
Low: $7.48
High: $46.23

Volume

3,308,137 shs

Average Volume

4,692,051 shs

Market Capitalization

$1.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13

Who are the company insiders with the largest holdings of Biohaven?

Biohaven's top insider shareholders include:
  1. John W Childs (Director)
  2. Gregory Bailey (Director)
  3. Vlad Coric (CEO)
  4. George C Clark (CAO)
  5. Irina Antonijevic (Director)
Learn More about top insider investors at Biohaven.

Who are the major institutional investors of Biohaven?

Biohaven's top institutional shareholders include:
  1. Vanguard Group Inc. — 2.72%
  2. JPMorgan Chase & Co. — 1.26%
  3. Qube Research & Technologies Ltd — 1.20%
  4. ARS Investment Partners LLC — 1.04%
  5. Capital Research Global Investors — 0.96%
  6. Caption Management LLC — 0.00%
Learn More about top institutional investors of Biohaven stock.

Which major investors are selling Biohaven stock?

During the last quarter, BHVN stock was sold by these institutional investors:
  1. Vanguard Group Inc.
  2. JPMorgan Chase & Co.
  3. Holocene Advisors LP
  4. TD Asset Management Inc
  5. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC
  6. Capital Fund Management S.A.
  7. ARS Investment Partners LLC
  8. Y Intercept Hong Kong Ltd

Which major investors are buying Biohaven stock?

During the last quarter, BHVN stock was bought by institutional investors including:
  1. Qube Research & Technologies Ltd
  2. Two Sigma Investments LP
  3. Vestal Point Capital LP
  4. Capital Research Global Investors
  5. Bank of America Corp DE
  6. Integral Health Asset Management LLC
  7. Susquehanna International Group LLP
  8. Squarepoint Ops LLC
Within the previous year, these company insiders have bought Biohaven stock:
  1. John W Childs (Director)
  2. Gregory Bailey (Director)
  3. Vlad Coric (CEO)
  4. George C Clark (CAO)
Learn More investors buying Biohaven stock.